AUGMENTED INTERFERON-GAMMA, INTERLEUKIN-4 AND TRANSFORMING GROWTH-FACTOR-BETA MESSENGER-RNA EXPRESSION IN BLOOD MONONUCLEAR-CELLS IN MYASTHENIA-GRAVIS

作者：LINK J^*; N**IKAS V; YU M; FREDRIKSON S; OSTERMAN PO; LINK H

来源：Journal of Neuroimmunology, 1994, 51(2): 185-192.

DOI：10.1016/0165-5728(94)90080-9

• INTERFERON-GAMMA
• TRANSFORMING GROWTH FACTOR-BETA
• INTERLEUKIN-4
• MYASTHENIA GRAVIS
• AUTOIMMUNITY

The abnormal T lymphocyte-dependent production of antibodies to the nicotinic acetylcholine receptor (AChR) in myasthenia gravis (MG) suggests a role for immunoregulatory cytokines. We examined the T helper type 1 (Th1) cell-associated interferon-gamma (IFN gamma) that promotes cell-mediated immunity, the Th2 cell-related interleukin-4 (IL-4) that augments B cell immunity, and transforming growth factor-beta (TGF-beta) that downregulates immune responses but enhances isotype switching. Blood mononuclear cells (MNC) expressing cytokine mRNA were enumerated after in situ hybridization with labelled complementary DNA oligonucleotide probes for IFN-gamma, IL-4 and TGF-beta. MG patients had elevated numbers of cells expressing IFN-gamma and IL-4 compared to patients with non-inflammatory neurological diseases and healthy controls, implying that both Th1-and Th2-like cells are involved in MG, TGF-beta-positive cells were also elevated in MG. The levels of cytokine-positive MNC were similar in MG and in control patients with other inflammatory neurological diseases. There were no associations between numbers of cytokine-positive blood MNC and clinical variables of MG, but individual patients need to be studied over the course of MG to clarify a relation between the cytokines under study and clinical or laboratory variables of MG.

• 出版日期1994-5